Live from the NIH registry
Studies recruiting near Gulfport right now
Top 25 of 37 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: SWOG Cancer Research Network
Tissue Repair Gel in Venous Leg Ulcers (US)
Venous Leg Ulcer, Venous Ulcer
Phase 3
Interventional 312 participants sought
Clincial Research Site 07 — D'Iberville, Mississippi (10.7 mi)
· Sponsor: TR Therapeutics
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component
Lung Cancer Screening
N/A
Interventional 200 participants sought
Memorial Hospital Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Timothy Mullett
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: NRG Oncology
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Obesity, Overweight
Phase 3
Interventional 125 participants sought
Dynamed Clinical Research, LP d/b/a DM Clinical Research — Gulfport, Mississippi (4.4 mi)
· Sponsor: Eli Lilly and Company
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Obesity, Overweight
Phase 3
Interventional 150 participants sought
MedPharmics, LLC — Gulfport, Mississippi (4.4 mi)
· Sponsor: Eli Lilly and Company
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Velocity Clinical Research, Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Pfizer
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Velocity Clinical Research - Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 3
Interventional 3,003 participants sought
AURORA-1 Clinical Site — Gulfport, Mississippi (4.4 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
Respiratory Distress Syndrome, Acute
Phase 2
Interventional 52 participants sought
Ocean Springs Hospital — Ocean Springs, Mississippi (14.5 mi)
· Sponsor: GEn1E Lifesciences
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Memorial Hospital Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Boehringer Ingelheim
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Obesity or Overweight
Phase 3
Interventional 2,000 participants sought
DelRicht Research at Gulfport Memorial — Gulfport, Mississippi (4.4 mi)
· Sponsor: Hoffmann-La Roche
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8
Phase 2
Interventional 2,900 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: National Cancer Institute (NCI)
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Hypertension
N/A
Interventional 261 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: SoniVie Inc.
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Obesity, Overweight
Phase 3
Interventional 1,560 participants sought
AURORA-2 Clinical Site — Gulfport, Mississippi (4.4 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
DelRicht Clinical Research - Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Ardelyx
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Phase 3
Interventional 698 participants sought
Memorial Hospital at Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: United Therapeutics
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
DelRicht Research — Gulfport, Mississippi (4.4 mi)
· Sponsor: TriGemX Bio, Inc.
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1068 — Gulfport, Mississippi (4.4 mi)
· Sponsor: Immunovant Sciences GmbH
Mobile Health for Adherence in Breast Cancer Patients
Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma
N/A
Interventional 410 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, Human
Phase 3
Interventional 54,000 participants sought
GSK Investigational Site — Gulfport, Mississippi (4.4 mi)
· Sponsor: GlaxoSmithKline
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 2
Interventional 249 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: Loxo Oncology, Inc.
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Cataract
Phase 3
Interventional 528 participants sought
Tekwani Vision Center — Bay Saint Louis, Mississippi (17.5 mi)
· Sponsor: Melt Pharmaceuticals